Disclaimer

The trademark information displayed on this page is public information and is provided for informational purposes only. This information may be incomplete, inaccurate, or outdated, and IndiaFilings does not guarantee its accuracy. IndiaFilings is an independent platform and is not associated, affiliated, or connected with any trademark listed in this database. We do not represent or speak on behalf of any such trademark. If you are trying to contact a specific trademark, please use their official channels. IndiaFilings cannot assist with queries directed at other companies.

ELDOXIME

Class 5Status: Objected
Application Number6210926
Trademark Status
Objected
Trademark Class5
Application Date2023-12-07
Proprietor NameREDLE PHARMACEUTICALS PVT LTD
Appropriate OfficeMUMBAI
StateMAHARASHTRA
Trademark TypeWORD
User Details09/05/2018
Agent NameG L VERMA[19424]
Agent AddressVERMA & CO, 221, V. B. PLAZA, PLOT-10, PKT-7, OPP. METRO, SECTOR-12, DWARKA, NEW DELHI-110078
Goods And Services Details[CLASS : 5] PHARMACEUTICAL, MEDICINAL PREPARATION AND FORMULATION

Identical Trademarks

Similar trademarks found for this brand

3 found
BrandClassStatus
ELDOXIME5Objected
ELDOXIME5Objected
ELDOXIME5Objected
Showing up to 6 identical trademarksView more on LEDGERS→

Trademark Protection

Automate the monitoring of your trademark application and filing of response to Government Objection or Hearing.

₹9,899+ GST

What's included:

✓
Brand Guard ( 1 application 1 class)
✓
Appointment of Lawyer
✓
Objection
✓
Hearing
✓
Infringement support (1)
✓
Power of Attorney (POA)

Frequently asked questions

Common questions about ELDOXIME.

What is the status of trademark application 6210926?
The current status of trademark application 6210926 for ELDOXIME is Objected.
What is the trademark class of ELDOXIME?
ELDOXIME is registered under trademark class 5.
Who is the proprietor of ELDOXIME?
The proprietor of ELDOXIME is REDLE PHARMACEUTICALS PVT LTD.
When was trademark application 6210926 filed?
Trademark application 6210926 for ELDOXIME was filed on 2023-12-07.